Thomas Gad, CHIEF BUSINESS OFFICER at Y-mAbs Therapeutics, Inc. (YMAB), sold 7,800 shares at $16.44 ($128K) on 2024-03-05, disclosed to the SEC on 2024-03-07.
Open-market sale of $128k YMAB by CHIEF BUSINESS OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.44 | 3,900 | $64K | 50.0% |
| 2 | $16.44 | 3,900 | $64K | 50.0% |
| Total | $16.44 avg | 7,800 | $128K | 100% |
| Filing → |
| YMAB | SELL | 2024-06-11 | $841K | — | Filing → |
| YMAB | SELL | 2024-05-23 | $396K | — | Filing → |
| YMAB | SELL | 2023-12-15 | $1.0M | — | Filing → |